Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
B 32.6 6.12% 1.88
RXRX closed up 6.12 percent on Wednesday, July 28, 2021, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Down
Historical RXRX trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Strong but Oversold Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Strong, Oversold and Reversal Signs Reversal 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 6.12%
Older End-of-Day Signals for RXRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 15 hours ago
Possible NR7 about 15 hours ago
50 DMA Resistance about 16 hours ago
Up 5% about 17 hours ago
60 Minute Opening Range Breakout about 17 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Industry Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Takeda Pharmaceutical Company Rare Monogenic Diseases

Is RXRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.81
52 Week Low 19.68
Average Volume 419,420
200-Day Moving Average 0.00
50-Day Moving Average 32.38
20-Day Moving Average 35.86
10-Day Moving Average 33.77
Average True Range 2.87
ADX 21.98
+DI 16.39
-DI 30.75
Chandelier Exit (Long, 3 ATRs) 34.20
Chandelier Exit (Short, 3 ATRs) 37.81
Upper Bollinger Bands 41.64
Lower Bollinger Band 30.08
Percent B (%b) 0.22
BandWidth 32.23
MACD Line -0.26
MACD Signal Line 0.48
MACD Histogram -0.7353
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.51
Resistance 3 (R3) 35.26 34.03 35.03
Resistance 2 (R2) 34.03 33.29 34.16 34.86
Resistance 1 (R1) 33.32 32.83 33.68 33.57 34.70
Pivot Point 32.09 32.09 32.27 32.22 32.09
Support 1 (S1) 31.38 31.35 31.74 31.63 30.50
Support 2 (S2) 30.15 30.89 30.28 30.34
Support 3 (S3) 29.44 30.15 30.18
Support 4 (S4) 29.69